How viral persistence and immune dysfunction drive long COVID

Study explores the biological drivers and mechanisms of long COVID, shedding light on its epidemiology and potential therapeutic interventions. It emphasizes the role of viral persistence, immune dysfunction, and coagulation in the development of this condition.

Digital health dealmaking is heating up

We’re in dealmaking season for publicly traded digital health companies. In the last week and a half, Progyny said it’s buying BenefitBump, a parental leave

February 7, 2025

Wondr Health Expands Weight Loss Program with Support for GLP-1 Users

What You Should Know: – Wondr Health, a leader in virtual metabolic health programs, has announced the expansion of its weight and obesity care solution,

November 20, 2024

Neuvivo makes bid to enter ALS arena with immunotherapy candidate – Pharmaceutical Technology

NP001 is designed to reestablish the balance of pro- and anti-inflammatory processes. Credits: David Herraez Calzada/Shutterstock.com Neuvivo has submitted a New Drug Application (NDA) for

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.